Combined hepatocellular cholangiocarcinoma: A clinicopathological update

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

1315

Figures (1-2)

125

Tables (1-3)

126

Sum=1613

Publishing Process of This Article

Item

Count

Browse

Download

Sum=88

May 27, 2024 (publication date) through Nov 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. May 27, 2024; 16(5): 766-775
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.766

Table 2 Common mutational signatures in hepatocellular carcinoma, combined hepatocellular-cholangiocarcinoma and cholangiocarcinoma

Cholangiocarcinoma	Hepatocellular carcinoma	Combined hepatocellular-cholangiocarcinoma
TP53	TERT promoter	TERT promoter
KRAS	TP53	TP53
IDH1	CTNNB1	MET
PTEN		ERBB2
ARID1A		KRAS
EPPK1		PTEN
ECE2
FYN

Citation: Vij M, Veerankutty FH, Rammohan A, Rela M. Combined hepatocellular cholangiocarcinoma: A clinicopathological update. World J Hepatol 2024; 16(5): 766-775
URL: https://www.wjgnet.com/1948-5182/full/v16/i5/766.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i5.766